Nordson Corporation
NASDAQ: NDSN
Stock price
326.87 USD
(+37.35%) 5 years
Financial Performance
5Y price score: 48
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 249%
%
ㅤ
By default your notes are visible only to you.
223.2
52-week range
339.1
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
4 %
Dividend Yield TTM
1 %
Market cap $
$ 18,213
Price / Earnings TTM
33.1
Price / Book TTM
5.6
PEG TTM
6.7
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
40.8 %
42.6 %
249 %
Free cash flow per share growth
6.5 %
50.3 %
255.4 %
Earnings per share growth
23.5 %
99.3 %
146.7 %
Founded: 1,935
Employees: 8,000
Business Summary:
Q&A
Contribute
By providing well-researched and detailed answer you increase your chance of becoming Top Contributor. TopFunds is free for all top contributors. Learn more
Latest Earnings Call Takeaways
2026 Q3 (Aug 20, 2026)
1) Strong Financial Performance
- Record sales of $818 million in Q3 2026, a 10% increase YoY, with 12% organic growth across all segments.
- Adjusted earnings per share reached $3.25, up 19% from the previous year.
- EBITDA of $262 million, representing 32% of sales, also a record for the company.
- Free cash flow of $237 million, with a conversion rate exceeding 100% of net income.
2) Segment Highlights
- Industrial Precision Solutions (IPS): Sales of $367 million, a 5% increase YoY, with organic growth of 3%. EBITDA margin held steady at 35%.
- Medical and Fluid Solutions (MFS): Achieved record sales of $231 million, with 11% organic growth. EBITDA margin improved to 38%.
- Advanced Technology Solutions (ATS): Sales reached $220 million, a 28% increase YoY, with 31% organic growth and an EBITDA margin of 30%.
3) Strategic Execution and Market Position
- The Ascend Strategy continues to drive growth, leveraging competitive advantages in differentiated products and customer relationships.
- Backlog increased by 35% YoY, indicating strong future demand and order entry momentum.
- The company is focused on maintaining high margins while pursuing growth opportunities in semiconductor and medical markets.
4) Challenges and Operational Focus
- The company is managing inflationary pressures and geopolitical factors impacting costs.
- IPS margins are stable but down YoY, reflecting a balance between growth and margin maintenance.
- Ongoing investments in innovation and operational excellence are aimed at enhancing productivity and profitability.
5) Guidance and Outlook
- Full-year sales guidance increased to $3.035 billion to $3.075 billion, with adjusted earnings expected between $11.80 and $12 per share.
- The company anticipates continued strong performance into FY 2027, particularly in ATS and MFS segments.
- M&A remains a strategic focus, with a healthy pipeline and disciplined criteria for acquisitions.
Bottom line: Nordson Corporation is demonstrating robust financial growth and operational strength, positioning itself well for continued success in the coming quarters, driven by strategic execution and a strong backlog. Shareholders can expect sustained value creation through disciplined growth and capital allocation strategies.
Annual Reports, Presentations And IR Contacts
Go to the websiteNordson Corporation — Financial Overview, Stock Price, Market Cap
Nordson Corporation is a company. Founded in 1935. As of October 9, 2026, the company's market capitalization is $18212542660 with a current stock price of $326.87.